Additionally, p53 protein is mutated in over 50% of PDAC, and tumor-associated mutant p53 (mutp53) protein has been well-known to drive aggressive cancer growth, invasion, metastasis, and chemotherapy resistance (42). This evidence concerns the gene TP53 and cancer.